371 related articles for article (PubMed ID: 33839095)
1. New developments in fetal and neonatal alloimmune thrombocytopenia.
Bussel JB; Vander Haar EL; Berkowitz RL
Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
[TBL] [Abstract][Full Text] [Related]
2. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
3. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
4. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
[TBL] [Abstract][Full Text] [Related]
5. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.
Wienzek-Lischka S; Sawazki A; Ehrhardt H; Sachs UJ; Axt-Fliedner R; Bein G
Arch Gynecol Obstet; 2020 Aug; 302(2):355-363. PubMed ID: 32495019
[TBL] [Abstract][Full Text] [Related]
7. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
[TBL] [Abstract][Full Text] [Related]
8. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
[TBL] [Abstract][Full Text] [Related]
9. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy.
Chen P; Li C; Lang S; Zhu G; Reheman A; Spring CM; Freedman J; Ni H
Blood; 2010 Nov; 116(18):3660-8. PubMed ID: 20647570
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia.
Curtis BR
Br J Haematol; 2015 Dec; 171(5):671-82. PubMed ID: 26344048
[TBL] [Abstract][Full Text] [Related]
11. Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopenia.
Lakkaraja M; Berkowitz RL; Vinograd CA; Manotas KC; Jin JC; Ferd P; Gabor J; Wissert M; McFarland JG; Bussel JB
Am J Obstet Gynecol; 2016 Oct; 215(4):471.e1-9. PubMed ID: 27131591
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
[TBL] [Abstract][Full Text] [Related]
13. Prenatal testing for hemolytic disease of the newborn and fetal neonatal alloimmune thrombocytopenia - current status.
Avent ND
Expert Rev Hematol; 2014 Dec; 7(6):741-5. PubMed ID: 25374152
[TBL] [Abstract][Full Text] [Related]
14. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future.
Serrarens-Janssen VM; Semmekrot BA; Novotny VM; Porcelijn L; Lotgering FK; Delemarre FM; Steegers EA
Obstet Gynecol Surv; 2008 Apr; 63(4):239-52. PubMed ID: 18348738
[TBL] [Abstract][Full Text] [Related]
15. Low-dose prednisone and immunoglobulin G treatment for woman at risk for neonatal alloimmune thrombocytopenia and T helper 1 immunity.
Skariah A; Sung N; Salazar Garcia MD; Wu L; Tikoo A; Gilman-Sachs A; Kwak-Kim J
Am J Reprod Immunol; 2017 Jun; 77(6):. PubMed ID: 28240400
[TBL] [Abstract][Full Text] [Related]
16. Fetal and neonatal alloimmune thrombocytopenia.
van den Akker ES; Oepkes D
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686
[TBL] [Abstract][Full Text] [Related]
17. Neonatal alloimmune thrombocytopenia: antenatal management.
Silver RM; Porter TF; Branch DW; Esplin MS; Scott JR
Am J Obstet Gynecol; 2000 May; 182(5):1233-8. PubMed ID: 10819864
[TBL] [Abstract][Full Text] [Related]
18. An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study.
Geisen C; Kjaer M; Fleck E; Skogen B; Armstrong R; Behrens F; Bhagwagar Z; Braeuninger S; Mortberg A; Olsen KJ; Gastón Schäfer SM; Walter C; Seifried E; Wikman A; Kjeldsen-Kragh J; Koehm M
J Thromb Haemost; 2023 Apr; 21(4):838-849. PubMed ID: 36696185
[TBL] [Abstract][Full Text] [Related]
19. [Thirty years of platelet immunology in fetal and neonatal alloimmune thrombocytopenia management, current situation].
Petermann R
Transfus Clin Biol; 2017 Sep; 24(3):166-171. PubMed ID: 28673503
[TBL] [Abstract][Full Text] [Related]
20. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
